REGIONAL VARIATIONS ACROSS THE UNITED STATES IN THE PREVALENCE OF OVERT HEPATIC ENCEPHALOPATHY AND RIFAXIMIN UTILIZATION AMONG COMMERCIALLY AND MEDICARE INSURED ADULTS

被引：0
|
作者：
Wong, Robert J. [1 ,2 ]
Dashputre, Ankur A. [3 ]
Gagnon-Sanschagrin, Patrick [4 ]
Heimanson, Zeev [5 ]
Maitland, Jessica
Bellefleur, Remi [4 ]
Guerin, Annie [4 ]
Sikes, Martha [3 ]
Bumpass, Brock [3 ]
Olujohungbe, Olamide [3 ]
Borroto, Danellys [3 ]
Joseph, George J. [3 ]
机构：
[1] VA Palo Alto Healthcare Syst, Palo Alto, CA USA
[2] Stanford Univ Sch Med, Stanford, CA USA
[3] Bausch Hlth, Laval, PQ, Canada
[4] Anal Grp Inc, Denver, CO USA
[5] Salix Pharmaceut, Bridgewater, NJ USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3100-A
引用
收藏
页码：S1408 / S1409
页数：2
相关论文
共 50 条
  • [31] UPTAKE OF TBO-FILGRASTIM IN THE OUTPATIENT SETTING AMONG COMMERCIALLY INSURED AND MEDICARE SUPPLEMENTAL POPULATIONS IN THE UNITED STATES
    Smoyer, K. E.
    Jones, C. A.
    Johnson, B. H.
    Lane, P. B.
    VALUE IN HEALTH, 2016, 19 (03) : A170 - A170
  • [32] Healthcare Resource Utilization and Costs Associated With Eosinophilic Esophagitis Among Commercially Insured Patients in the United States
    Xia, Qian
    Tencer, Tom
    Jobson, Greeta
    Qian, Ellen
    Dellon, Evan S.
    Biswas, Mousumi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (11): : 2326 - 2330
  • [33] Psychiatric prescription drug utilization and related overdoses among commercially insured individuals in the United States, 2020
    Russo, Ellyn M.
    Rubin, Danielle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 339 - 340
  • [34] Utilization Pattern of Phosphodiesterase Type 5 (PDE5) Inhibitors for Erectile Dysfunction among Commercially Insured Adults in the United States
    Liu, Wei
    Dahm, Philipp
    Gerhard, Tobias
    Antonelli, Patrick
    Delaney, Joseph Chris
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 85 - 86
  • [35] HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH ESSENTIAL TREMOR: A RETROSPECTIVE OBSERVATIONAL STUDY IN A UNITED STATES COMMERCIALLY INSURED AND MEDICARE ADVANTAGE POPULATION
    Dai, D.
    Fernandes, J.
    Samiian, A.
    Coetzer, H.
    VALUE IN HEALTH, 2021, 24 : S161 - S161
  • [36] Hepatitis delta treatment utilization in the United States: an analysis of commercially insured adults with hepatitis delta virus infection
    Wong, Robert
    Gish, Robert G.
    Lim, Joseph
    Kaushik, Ankita
    Kim, Chong
    Leung, Gary
    Jacobson, Ira M.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1072 - S1073
  • [37] GEOGRAPHIC VARIATION IN THE PREVALENCE OF NAFLD WITH AND WITHOUT CIRRHOSIS AMONG INSURED ADULTS IN THE UNITED STATES
    Gedallovich, Seren M.
    Stephen, John
    Kang, Raymond
    Aikman, Cassandra
    Mazumder, Nikhilesh
    Ladner, Daniela P.
    Parker, Emily D.
    Ackermann, Ronald T.
    VanWagneru, Lisa B.
    HEPATOLOGY, 2020, 72 : 969 - 969
  • [38] Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018
    Ladner, Daniela P.
    Gmeiner, Michael
    Hasjim, Bima J.
    Mazumder, Nikhilesh
    Kang, Raymond
    Parker, Emily
    Stephen, John
    Polineni, Praneet
    Chorniy, Anna
    Zhao, Lihui
    Vanwagner, Lisa B.
    Ackermann, Ronald T.
    Manski, Charles F.
    PLOS ONE, 2024, 19 (02):
  • [39] Declining Use of Primary Care Among Commercially Insured Adults in the United States, 2008-2016
    Ganguli, Ishani
    Shi, Zhuo
    Orav, E. John
    Rao, Aarti
    Ray, Kristin N.
    Mehrotra, Ateev
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (04) : 240 - +
  • [40] ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE AMONG COMMERCIALLY INSURED ADULTS DIAGNOSED WITH COLORECTAL CANCER IN THE UNITED STATES
    Davies-Teye, B. B.
    Slejko, J. F.
    Lee, T. Y.
    Onukwugha, E.
    VALUE IN HEALTH, 2022, 25 (12) : S91 - S91
12345